Outlook Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $51k | 48k | 1.06 |
| 2025-06-30 | $88k | 55k | 1.60 |
| 2025-03-31 | $115k | 95k | 1.22 |
| 2024-12-31 | $542k | 287k | 1.89 |
| 2024-09-30 | $38k | 7.2k | 5.34 |
| 2024-06-30 | $18k | 2.4k | 7.38 |
| 2024-03-31 | $111k | 9.3k | 11.94 |